Publications
- Immunotherapy and radiotherapy in locally advanced (metastatic) non small cell lung cancer2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report2020 | Faculty of Medicine in Pilsen
- Immunotherapy in squamous NSCLC - nivolumab clinical data, our experiences with nivolumab treatment2018 | Faculty of Medicine in Pilsen
- Immunotherapy in the treatment of non-small cell lung cancer2017 | Faculty of Medicine in Pilsen
- Management of diarrhea as an undesirable effect of treatment with afatinib - case report2017 | Faculty of Medicine in Pilsen
- Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment2016 | Faculty of Medicine in Pilsen
- Diagnostic and therapeutic guidelines for stage III non-small-cell lung cancer2016 | Faculty of Medicine in Pilsen
- Therapy of metastatic non-squamous lung cancer with bevacizumab plus pemetrexed2016 | Faculty of Medicine in Pilsen
- What else after the failure of the first line EFGR-TKI treatment2015 | Faculty of Medicine in Pilsen
- Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically treated patients with non-small cell lung cancer2014 | Faculty of Medicine in Pilsen
Loading network view...